Qiagen NVXTER:QIA -1.01%74 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates XTER:QIA with a GF Score™ of 74/100 and a GF Value™ of €45.46 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 55 Medical Diagnostics & Research companies, Qiagen NV ranks better than 90.91% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Qiagen NV's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Qiagen NV's Dividend Payout Ratio or its related term are showing as below:
XTER:QIA'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11 Med: 0.12 Max: 0.12
Current: 0.11
During the past 13 years, the highest Dividend Payout Ratio of Qiagen NV was 0.12. The lowest was 0.11. And the median was 0.12.
XTER:QIA's Dividend Payout Ratio is ranked better than 90.91% of 55
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.49
vs XTER:QIA: 0.11
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Qiagen NV (XTER:QIA) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Qiagen NV Dividend Payout Ratio Related Terms
Qiagen NV Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Qiagen NV's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:QIA vs TWST, CRL, BLLN: Dividend Payout Ratio Comparison
For the Diagnostics & Research subindustry, Qiagen NV's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qiagen NV Dividend Payout Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Qiagen NV's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Qiagen NV's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV (XTER:QIA) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Qiagen NV and its competitors. Over the past decade, Qiagen NV's Dividend Payout Ratio has ranged from 0.11 to 0.12. According to the industry distribution chart, Qiagen NV ranks #5 out of 55 companies in the Medical Diagnostics & Research industry, placing it in the top 9.1%.
Is Qiagen NV's Dividend Payout Ratio too high?
Qiagen NV's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.12. Based on the distribution chart, Qiagen NV ranks #5 out of 55 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Qiagen NV has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qiagen NV's Dividend Payout Ratio compare to TWST and CRL?
According to the Medical Diagnostics & Research industry distribution chart, Qiagen NV ranks #5 out of 55 companies for Dividend Payout Ratio. This places Qiagen NV in the top 9% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.49. Historically, Qiagen NV's own Dividend Payout Ratio has ranged from 0.11 to 0.12 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.49, based on 55 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Qiagen NV and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qiagen NV's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qiagen NV stock overvalued right now?
Based on GuruFocus' analysis, Qiagen NV (XTER:QIA) is currently considered Modestly Undervalued. The stock's GF Value™ is €45.46, compared to a current price of €34.63 — trading 23.8% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Qiagen NV's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Qiagen NV (XTER:QIA), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qiagen NV (XTER:QIA) Overvalued in 2026?
Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued.
The current stock price of €34.63 is trading 23.8% below its estimated GF Value™ of €45.46.
GuruFocus considers Qiagen NV to be Modestly Undervalued.
Key valuation signals for XTER:QIA:
Dividend Payout Ratio: 0.00
GF Value™: €45.46 vs. price of €34.63 (23.8% below fair value)
No single metric tells the full story. See the XTER:QIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
74GF Score
Get the complete analysis for XTER:QIA
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:QIA has been successfully added to your 
